- Home
- ARCT vs NKX Comparison
ARCT vs NKX Comparison
Compare ARCT & NKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- NKX
- Stock Information
- Founded
- ARCT 2013
- NKX 2002
- Country
- ARCT United States
- NKX United States
- Employees
- ARCT N/A
- NKX N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- NKX Finance/Investors Services
- Sector
- ARCT Health Care
- NKX Finance
- Exchange
- ARCT Nasdaq
- NKX Nasdaq
- Market Cap
- ARCT 298.3M
- NKX 549.4M
- IPO Year
- ARCT N/A
- NKX N/A
- Fundamental
- Price
- ARCT $13.19
- NKX $11.77
- Analyst Decision
- ARCT Strong Buy
- NKX
- Analyst Count
- ARCT 8
- NKX 0
- Target Price
- ARCT $52.33
- NKX N/A
- AVG Volume (30 Days)
- ARCT 497.0K
- NKX 109.3K
- Earning Date
- ARCT 08-04-2025
- NKX 01-01-0001
- Dividend Yield
- ARCT N/A
- NKX 4.37%
- EPS Growth
- ARCT N/A
- NKX N/A
- EPS
- ARCT N/A
- NKX N/A
- Revenue
- ARCT $143,680,000.00
- NKX N/A
- Revenue This Year
- ARCT N/A
- NKX N/A
- Revenue Next Year
- ARCT $34.79
- NKX N/A
- P/E Ratio
- ARCT N/A
- NKX N/A
- Revenue Growth
- ARCT 15.38
- NKX N/A
- 52 Week Low
- ARCT $8.04
- NKX $9.78
- 52 Week High
- ARCT $25.88
- NKX $12.00
- Technical
- Relative Strength Index (RSI)
- ARCT 66.19
- NKX 54.66
- Support Level
- ARCT $12.03
- NKX $11.44
- Resistance Level
- ARCT $14.75
- NKX $11.68
- Average True Range (ATR)
- ARCT 0.79
- NKX 0.09
- MACD
- ARCT 0.20
- NKX 0.03
- Stochastic Oscillator
- ARCT 89.96
- NKX 100.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About NKX Nuveen California AMT-Free Quality Municipal Income Fund
Nuveen California AMT-Free Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objectives are to provide current income exempt from regular federal and California income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.